HK Stock Market Move | TH MEDICAL-B(02697) Surges Over 18% in Early Trading; Overseas Partners Visit Successively; Company's Core Product CE Certification Expected to Be Approved Within the Year

TH MEDICAL-B(02697) surged over 18% in early trading this morning. As of press time, it was up 13.74% at HK$59.60, with a turnover of HK$56.3099 million. On the news front, following the visit from its Brazilian partner, on November 12, a partner from Germany visited True Health Medical to conduct on-site inspections and in-depth research. During the visit, the partner observed core products such as the puncture surgery Siasun Robot&Automation and microwave ablation surgery Siasun Robot&Automation up close, and held thorough discussions on the products' technical principles, clinical advantages, and application scenarios. The company is currently accelerating its international strategic layout, while overseas registration work is progressing steadily. CE certification for its core products is expected to be approved within the year, opening a key market access channel for entry into the EU and related recognized markets. True Health Medical is the first high-end medical equipment company in China to simultaneously cover three Siasun Robot&Automation technology routes: "puncture + ablation + organ preservation." To date, the company has obtained 10 Class III medical device registration certificates and 5 Class II medical device registration certificates, applied for more than 350 intellectual property rights, and its related products have entered more than 100 hospitals for clinical work. They are used in puncture biopsy, surgical positioning, precision ablation, seed implantation, and many other diagnostic and therapeutic procedures for thoracic and abdominal organs, with over 9,000 surgeries completed and a 100% technical success rate, earning high recognition from clinicians.